[go: up one dir, main page]

NO20011371D0 - Kjemokinreseptorantagonist og cyklosporin i kombinert terapi - Google Patents

Kjemokinreseptorantagonist og cyklosporin i kombinert terapi

Info

Publication number
NO20011371D0
NO20011371D0 NO20011371A NO20011371A NO20011371D0 NO 20011371 D0 NO20011371 D0 NO 20011371D0 NO 20011371 A NO20011371 A NO 20011371A NO 20011371 A NO20011371 A NO 20011371A NO 20011371 D0 NO20011371 D0 NO 20011371D0
Authority
NO
Norway
Prior art keywords
cyclosporin
receptor antagonist
chemokine receptor
combined therapy
therapy
Prior art date
Application number
NO20011371A
Other languages
English (en)
Other versions
NO20011371L (no
Inventor
Hermann-Joseph Grone
Peter J Nelson
Amanda Proudfoot
Timothy N C Wells
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Research Systems filed Critical Applied Research Systems
Publication of NO20011371D0 publication Critical patent/NO20011371D0/no
Publication of NO20011371L publication Critical patent/NO20011371L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19Cytokines; Lymphokines; Interferons
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/521Chemokines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Transplantation (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
NO20011371A 1998-09-18 2001-03-16 Kjemokinreseptorantagonist og cyklosporin i kombinert terapi NO20011371L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98117697A EP1000626A1 (en) 1998-09-18 1998-09-18 Chemokine receptor antagonist and cyclosporin in combined therapy
PCT/EP1999/006844 WO2000016796A1 (en) 1998-09-18 1999-09-16 Chemokine receptor antagonist and cyclosporin in combined therapy

Publications (2)

Publication Number Publication Date
NO20011371D0 true NO20011371D0 (no) 2001-03-16
NO20011371L NO20011371L (no) 2001-03-16

Family

ID=8232654

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20011371A NO20011371L (no) 1998-09-18 2001-03-16 Kjemokinreseptorantagonist og cyklosporin i kombinert terapi

Country Status (23)

Country Link
US (1) US6902728B1 (no)
EP (2) EP1000626A1 (no)
JP (1) JP2003519082A (no)
KR (1) KR100613950B1 (no)
CN (1) CN1177613C (no)
AR (1) AR021810A1 (no)
AT (1) ATE227582T1 (no)
AU (1) AU766595B2 (no)
BR (1) BR9913846A (no)
CA (1) CA2344370A1 (no)
DE (1) DE69903964T2 (no)
DK (1) DK1113811T3 (no)
EA (1) EA003181B1 (no)
EE (1) EE04705B1 (no)
ES (1) ES2186411T3 (no)
HK (1) HK1041225B (no)
IL (2) IL141899A0 (no)
NO (1) NO20011371L (no)
PT (1) PT1113811E (no)
SI (1) SI1113811T1 (no)
UA (1) UA60379C2 (no)
WO (1) WO2000016796A1 (no)
ZA (1) ZA200101909B (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7259136B2 (en) 1999-04-30 2007-08-21 Amylin Pharmaceuticals, Inc. Compositions and methods for treating peripheral vascular disease
US6740636B2 (en) 2000-07-31 2004-05-25 Schering Aktiengesellschaft Non-peptide CCR1 receptor antagonists in combination with cyclosporin A for the treatment of heart transplant rejection
LT5132B (lt) 2000-07-31 2004-05-25 Schering Aktiengesellschaft Nepeptidiniai ccr1 receptorių antagonistai derinyje su ciklosporinu a širdies transplanto atmetimui gydyti
US8012474B2 (en) 2007-08-02 2011-09-06 Nov Immune S.A. Anti-RANTES antibodies
WO2017040520A1 (en) 2015-08-31 2017-03-09 Hitachi Chemical Co., Ltd. Molecular methods for assessing urothelial disease
JP6733968B2 (ja) * 2015-08-31 2020-08-05 日立化成株式会社 腎移植後合併症を評価するための分子法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI972433A7 (fi) * 1994-12-08 1997-06-06 Glaxo Group Ltd Rantes-peptidi ja fragmentteja sekä tätä sisältäviä tulehduksen hoitoo n soveltuvia koostumuksia
WO1997005896A1 (en) * 1995-08-09 1997-02-20 Schering Corporation Combined use of interleukin-10 and cyclosporin for immunosuppression therapy
WO1998006703A1 (en) * 1996-08-14 1998-02-19 Warner-Lambert Company 2-phenyl benzimidazole derivatives as mcp-1 antagonists
WO1998006751A1 (en) * 1996-08-16 1998-02-19 Research Corporation Technologies, Inc. Mcp-3, rantes and mip-1alpha receptor antagonists

Also Published As

Publication number Publication date
IL141899A (en) 2007-12-03
KR100613950B1 (ko) 2006-08-18
HK1041225A1 (en) 2002-07-05
EA200100366A1 (ru) 2001-08-27
SI1113811T1 (en) 2003-04-30
EE200100159A (et) 2002-08-15
PT1113811E (pt) 2003-03-31
EP1113811B1 (en) 2002-11-13
CN1177613C (zh) 2004-12-01
WO2000016796A1 (en) 2000-03-30
HK1041225B (zh) 2005-04-22
DK1113811T3 (da) 2003-03-10
EP1113811A1 (en) 2001-07-11
AU766595B2 (en) 2003-10-16
ZA200101909B (en) 2001-09-11
UA60379C2 (uk) 2003-10-15
ATE227582T1 (de) 2002-11-15
IL141899A0 (en) 2002-03-10
EP1000626A1 (en) 2000-05-17
CN1319021A (zh) 2001-10-24
EA003181B1 (ru) 2003-02-27
DE69903964T2 (de) 2003-03-27
CA2344370A1 (en) 2000-03-30
AR021810A1 (es) 2002-08-07
EE04705B1 (et) 2006-10-16
BR9913846A (pt) 2001-06-05
JP2003519082A (ja) 2003-06-17
NO20011371L (no) 2001-03-16
ES2186411T3 (es) 2003-05-01
US6902728B1 (en) 2005-06-07
KR20010075060A (ko) 2001-08-09
AU6191499A (en) 2000-04-10
DE69903964D1 (en) 2002-12-19

Similar Documents

Publication Publication Date Title
IS6411A (is) Kaspasa tálmar og notkun þeirra
NL300395I1 (nl) GnRH antagonisten gemodificeerd in posities 5 en 6
NO20014560D0 (no) Quinasoliner og terapautisk anvendelse derav
EP1541585A4 (en) CXCR4 ANTAGONIST AND USE THEREOF
LU91501I2 (fr) Sugammadex et ses sels pharmaceutiquement acceptables-BRIDION
NO994438D0 (no) Terapeutisk aktive diarylpropylaminer samt fremstilling og anvendelse derav
DE69841509D1 (de) Lektrodenfomstück und elektrochemische elemente
NO20005190L (no) Terapeutiske angiogene faktorer og fremgangsmåter til anvendelse derav
IS6183A (is) Díamínóþíazol og notagildi þeirra til að hindra prótín kínasa
NO991150D0 (no) Pyrazolopyrimidiner og pyrazolotriaziner
DK1076704T3 (da) IL-2-selektive agonister og antagonister
IS5928A (is) Aðferðir og samsetningar til að hindra lyfjaþol
NO20004274D0 (no) Proteaseaktivert reseptor 4 og anvendelse derav
NO20010804D0 (no) Muskariniske agonister og antagonister
TR199701645A3 (tr) Vitronektin reseptör antagonistleri,bunlarin imalati ve kullanimi
DK1068238T3 (da) Integrinheterodimer og subunit deraf
NO20011371D0 (no) Kjemokinreseptorantagonist og cyklosporin i kombinert terapi
PT1178981E (pt) 3-piridil-4-arilpirrois substituidos e metodos terapeuticos e profilacticos
NO974057D0 (no) Bisykliske takykinin-antagonister, fremstilling derav og deres anvendelse i farmasöytisk sammensetning
HU0000744D0 (en) Transposing unit and flaw
NO20025135D0 (no) Antihypertensive midler og anvendelse
EP1229795A4 (en) CHIMIOKINE BETA 13 HUMAN
NO20021475D0 (no) Vasopressinantagonist, formulering og fremgangsmåte
NO984694D0 (no) Formasjonstesteanordning med st°yreduksjonsevne og tilknyttede fremgangsmÕter
NO307128B1 (no) Katamaran og trimaranski

Legal Events

Date Code Title Description
CREP Change of representative

Representative=s name: ONSAGERS AS, POSTBOKS 6963 ST OLAVS PLASS, 0130 OS

FC2A Withdrawal, rejection or dismissal of laid open patent application